![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
C49 + CC Journal Club For more information, please refer to our special emails from April 13 and May 19. |
Inflammatory Bowel Diseases |
Free Subscription
3 Aliment Pharmacol Ther |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Inflammatory Bowel Diseases is free of charge.
Editorial: Real-World Effectiveness of Mirikizumab in Ulcerative Colitis-A
Valuable but Preliminary Glimpse. Authors' Reply.
Aliment Pharmacol Ther. 2025 May 5. doi: 10.1111/apt.70180.
PubMed
Editorial: Real-World Effectiveness of Mirikizumab in Ulcerative Colitis-A
Valuable but Preliminary Glimpse.
Aliment Pharmacol Ther. 2025 May 5. doi: 10.1111/apt.70160.
PubMed
Long-Term Outcomes Following Withdrawal of Anti-Tumour Necrosis Factor Treatment
in Inflammatory Bowel Disease Patients in Remission: The Exit Long-Term Study of
GETECCU.
Aliment Pharmacol Ther. 2025 May 2. doi: 10.1111/apt.70172.
PubMed
Abstract available
HLA DQA1*05 and Risk of Antitumor Necrosis Factor Treatment Failure and Anti-Drug
Antibody Development in Children With Crohn's Disease.
Am J Gastroenterol. 2025;120:1076-1086.
PubMed
Abstract available
Association between Dietary Inflammatory Index and Ulcerative Colitis: a
case-control study.
BMC Gastroenterol. 2025;25:343.
PubMed
Abstract available
Eosinophilic esophagitis patients report substantial disease burden comparable to
more systemic immune-mediated diseases.
BMC Gastroenterol. 2025;25:336.
PubMed
Abstract available
Medical Therapy for Acute Severe Ulcerative Colitis: A Systematic Review with
Meta-analysis.
Clin Gastroenterol Hepatol. 2025 May 6:S1542-3565(25)00329.
PubMed
Abstract available
Differentiating IL-23 Inhibitors in Crohn's Disease.
Drugs. 2025 May 5. doi: 10.1007/s40265-025-02183.
PubMed
Abstract available
Optimizing outcomes with maintenance IV UST in highly bio-exposed patients with
IBD. Efficacy and adjusted regimen in real world.
Gastroenterol Hepatol. 2025;48:502253.
PubMed
Abstract available
Creeping Fat and Muscle Hyperplasia in Crohn's Disease: A Critical Mechanistic
Link for Stricture Formation.
Gastroenterology. 2025 May 2:S0016-5085(25)00665.
PubMed
The importance of the mesentery in the pathophysiology of Crohn's disease.
Gastroenterology. 2025 May 2:S0016-5085(25)00664.
PubMed
Non-Typhoidal Salmonella Infections and Inflammatory Bowel Disease Risk: New
Findings and Multidimensional Perspectives for Future Research.
Inflamm Bowel Dis. 2025 May 5:izaf082. doi: 10.1093.
PubMed
Multifaceted Endoscopic Approach (Stricturotomy, Balloon Dilation, Fistulotomy,
and Seton Placement) Guided by Intestinal Ultrasound to Avert Surgery in
Complicated Crohn's Disease During Lactation.
Inflamm Bowel Dis. 2025 May 2:izaf076. doi: 10.1093.
PubMed
Disparities in Access and Treatment for Rural Patients With Inflammatory Bowel
Disease: A Survey of Inflammatory Bowel Disease Patients and Providers.
Inflamm Bowel Dis. 2025 May 8:izaf090. doi: 10.1093.
PubMed
Abstract available
Monitoring Structural Bowel Damage in Patients With Crohn's Disease Using
Intestinal Ultrasonography: Can It Be Reversed by Biological Treatment?
Inflamm Bowel Dis. 2025 May 8:izaf100. doi: 10.1093.
PubMed
Abstract available
Crohn's Disease Stricture Response to Treatment Assessed with Magnetic Resonance
Imaging and Intestinal Ultrasound: STRIDENT Randomized Trial.
Inflamm Bowel Dis. 2025 May 8:izaf073. doi: 10.1093.
PubMed
Abstract available
Be precise, be reproducible! The emerging role of artificial intelligence in
inflammatory bowel disease endoscopy.
J Crohns Colitis. 2025;19:jjaf046.
PubMed
Association between inflammatory bowel disease, current therapies, and
cardiovascular events: a review and meta-analysis of data from 2.2 million
individuals.
J Crohns Colitis. 2025 May 7:jjaf078. doi: 10.1093.
PubMed
Abstract available
Spatial mapping and geographic variation of inflammatory bowel disease in Canada:
A population-based study.
J Crohns Colitis. 2025 May 6:jjaf079. doi: 10.1093.
PubMed
Abstract available
Differential effects of tofacitinib on macrophage activation contribute to lack
of response in ulcerative colitis patients.
J Crohns Colitis. 2025 May 5:jjaf076. doi: 10.1093.
PubMed
Abstract available
Isolated perianal Crohn's disease: a systematic review and expert consensus
proposing novel diagnostic criteria and management advice.
Lancet Gastroenterol Hepatol. 2025 Apr 29:S2468-1253(25)00007.
PubMed
Abstract available
De novo DUOX2 expression in neutrophil subsets shapes the pathogenesis of
intestinal disease.
Proc Natl Acad Sci U S A. 2025;122:e2421747122.
PubMed
Abstract available
Thank you for your interest in scientific medicine.